Bicuspid Aortic Valve (BAV) Registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• Healthy volunteers accepted
• Adult, Older adult

Study population: Primary clinic

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry

Conditions

Bicuspid Aortic Valve

Keywords

Bicuspid Aortic Valve Disease, Bicuspid Aortic Valve, BAV

Medical subject headings

Bicuspid Aortic Valve Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Characterizing patients with bicuspid aortic valve disease

   Identifying patients with bicuspid aortic valve disease, assessing the effect of medical intervention.

   Measured: 30 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted25 Dec 2012 (estimated)
2. Study startApr 2010
3. Primary completionDec 2040 (estimated)
4. Study completionDec 2040 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Bicuspid Aortic ValveStudies of the same condition, open and under way.
• More trials run by University of MichiganThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.